Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Relmada Therapeutics Inc (Relmada Therapeutics) is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. The company’s pipeline product
Headquarters
United States of America
Address
3rd Floor, 2222 Ponce De Leon Boulevard, Coral Gables, Florida, 33134
Website
www.relmada.com
Telephone
1 786 6291376
No of Employees
17
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
RLMD (NASD)
EPS
XYZ
Net Income (2024)
XYZ
28.3%
(2024 vs 2023)
Market Cap*
$434.2M
Net Profit Margin (0 vs)
XYZ
0.0%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products |
|---|
| Pipeline |
| NDV-01: Non-Muscle Invasive Bladder Cancer |
| Sepranolone: Prader-Willi Syndrome (PWS) |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Asset Purchase | In February, the company acquired Sepranolone for the treatment of Tourette syndrome and other compulsion-related conditions from Asarina Pharma AB. |
| 2021 | Acquisitions/Mergers/Takeovers | In July, the company announced the acquisition of development and commercial rights to a novel psilocybin and derivate program from Arbormentis LLC. |
| 2018 | Acquisitions/Mergers/Takeovers | In January, Relmada Therapeutics acquired the global rights to develop and market dextromethadone (REL-1017), a novel N-methyl-D-aspartate receptor antagonist to treat disorders of the nervous system. |
Competitor Comparison
| Key Parameters | Relmada Therapeutics Inc | Alpine Immune Sciences Inc | Cidara Therapeutics Inc | EOM Pharmaceuticals Holdings Inc | Juno Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Coral Gables | Seattle | San Diego | Westlake Village | Seattle |
| State/Province | Florida | Washington | California | California | Washington |
| No. of Employees | 17 | 142 | 38 | 3 | 533 |
| Entity Type | Public | Private | Private | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Charles J. Casamento | Chairman | Executive Board | 2017 | 77 |
| Sergio Traversa | Chief Executive Officer; Director | Executive Board | 2012 | 63 |
| Paul Kelly | Chief Operating Officer; Director | Executive Board | 2015 | 65 |
| Maged Shenouda | Chief Financial Officer | Senior Management | 2020 | 59 |
| Charles Ence | Chief Accounting Officer; Chief Compliance Officer | Senior Management | 2020 | 64 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer